Pathogenesis of a variant in the 5′ untranslated region of ADAR1 in dyschromatosis symmetrica hereditaria.

Publication date: Jan 11, 2020

Dyschromatosis symmetrica hereditaria (DSH) is a pigmentary genodermatosis caused by mutations in ADAR1. In this study, we performed mutation analysis on a family that included typical DSH patients. No mutations were found in any coding regions or exon-intron boundary regions of ADAR1, but a previously unreported non-coding heterozygous variant, c.-60A>G, was found in the 5′ untranslated region (5’UTR) of ADAR1 in the proband and her mother. The function of 5’UTR in mRNA is not well understood. To understand the pathogenesis of the variant and the function of the 5’UTR of ADAR1, we constructed 2 reporter genes carrying the ADAR1 5’UTR sequence with/without the variant between the PGK promoter and a luciferase coding sequence, and performed luciferase assays, semi-quantitative PCR analyses and polysomal assays. In human melanocytes, c.-60A>G induced a 16% reduction in transcription and a 51% reduction in translation. Our results indicate that the 5’UTR c.-60A>G variant adversely affects the post-transcriptional step in gene expression, leading to DSH. Detailed functional assays of the 5’UTR of ADAR1 in the present study revealed the gene expression to be not only downregulated, but also upregulated by defects in 5’UTR depending on the locations. The regulation of translation by 5’UTR is very complicated.

Suganuma, M., Kono, M., Yamanaka, M., and Akiyama, M. Pathogenesis of a variant in the 5′ untranslated region of ADAR1 in dyschromatosis symmetrica hereditaria. 25424. 2020 Pigment Cell Melanoma Res.

Concepts Keywords
ADAR1 Nucleic acids
Coding Sequence Gene expression
Exon RNA
Heterozygous Spliceosome
Intron DNA
Luciferase ADAR
Melanocytes Dyschromatosis symmetrica hereditaria
Melanoma Untranslated region
MRNA Messenger RNA
Mutation Coding region
Pathogenesis Exon
Quantitative PCR


Type Source Name
disease MESH dyschromatosis symmetrica hereditaria
disease MESH defects
drug DRUGBANK Adenosine


Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *